Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Open Label Study of the Effects of a Five Minute Infusion Time for Ethyol (Amifostine) in Patients Undergoing Chemotherapy

NCT00003252 is registered in ClinicalTrials.gov with Rush North Shore Medical Center as lead sponsor.

NCT NCT00003252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Open Label Study of the Effects of a Five Minute Infusion Time for Ethyol (Amifostine) in Patients Undergoing Chemotherapy
Lead sponsor
Rush North Shore Medical Center
Phase
Phase 4
Overall status
Completed
Start date
December 31, 1997
Completion date
September 30, 2004
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug/agent toxicity by tissue/organ, unspecified adult solid tumor, protocol specific